| Completed | Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-A Pharmacokinetics, Pharmacodynamics | Phase 2 / Phase 3 | 2022-08-22 |
| Completed | Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Inject Pharmacokinetics, Epinephrine, Albuterol | Phase 4 | 2019-12-09 |
| Completed | Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers Asthma | Phase 2 | 2014-08-01 |
| Completed | Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation Asthma | Phase 2 | 2014-07-01 |
| Terminated | Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults Asthma | Phase 1 / Phase 2 | 2012-11-01 |
| Completed | Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma Asthma | Phase 3 | 2012-10-01 |
| Completed | Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP) Allergic Skin Reaction | Phase 2 | 2012-09-01 |
| Completed | Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation Asthma | Phase 2 | 2012-04-01 |
| Completed | Safety Study in Adolescent and Adult Patients With Asthma Asthma | Phase 3 | 2011-11-01 |
| Completed | Evaluation of Efficacy and Safety of E004 in Children With Asthma Asthma | Phase 3 | 2011-10-01 |
| Completed | Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients Asthma | Phase 3 | 2011-07-01 |
| Completed | Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS Asthma | Phase 2 | 2010-12-01 |
| Completed | Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics Asthma, Bronchospasm, Wheezing | Phase 1 / Phase 2 | 2010-08-01 |
| Completed | Dose-Ranging Study of A006 DPI, in Adult Asthma Patients Asthma, Bronchospasm | Phase 2 | 2010-07-01 |
| Completed | Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006 Asthma, Bronchospasm, Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2010-07-01 |
| Completed | Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers Asthma | Phase 1 / Phase 2 | 2010-01-01 |
| Terminated | Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients. Asthma | Phase 1 / Phase 2 | 2009-12-01 |
| Terminated | 4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma Asthma | Phase 3 | 2008-03-01 |
| Terminated | Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction Asthma, Bronchospasm | Phase 3 | 2008-02-01 |
| Terminated | Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients Asthma | Phase 3 | 2007-09-01 |